Merck & Co., Inc.'s ROTATEQ(R) (Rotavirus Vaccine, Live, Oral, Pentavalent) Awarded Prix Galien USA 2010 Top Honor

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent), Merck’s vaccine for rotavirus gastroenteritis in infants and children, received the Prix Galien USA 2010 Award for Best Biotechnology Product, Merck announced today.

MORE ON THIS TOPIC